Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Esperion Therapeutics Inc. logo

Esperion Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

2.63
 
USD
  
0.02
  
(0.77%)
Optionable: Yes  Market Cap: 305 M  90-day average vol: 6,262,599

Previous close: 2.61  Open: 2.65  Bid: 2.62  Ask: 2.65
52 week range    
0.70   
   6.75
Peers   
RARE / 
BMRN / 
FOLD / 
LXRX / 
PFE / 
Last updated: Friday 23rd February 2024
45
MarketXLS Rank
40
Value
61
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BMRN

16 B886.389.37

FOLD

3 B-10.59.26

LXRX

0 B-6.73.1

PFE

0.0302298 B15.153.21

RARE

5 B-13.369.79

REGN

66 B9.7622.36
Financials

ESPR Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-3.59-5.23-9.31-3.52
Basic EPS total-3.59-5.23-9.31-3.52
Basic weighted shares outstanding8 M16 M22 M23 M24 M27 M27 M27 M29 M66 M
Depreciation-71000.0-160000.0-236000.0-252000.0-258000.0-265000.0319000.0547000.0612000.0500000.0
DepreciationAndAmortization-71000.0-160000.0-236000.0-252000.0-258000.0-265000.0319000.0547000.0612000.0500000.0
Diluted EPS total-3.31-2.22-2.26-3.33-6.98-7.54-3.59-5.23-9.31-3.52
Diluted normalized net income/share-9.31-3.52
Diluted weighted shares outstanding8 M16 M22 M23 M24 M27 M27 M27 M29 M66 M
GeneralAndAdministrativeExpense7 M11 M20 M18 M21 M33 M66 M200 M185 M109 M
Gross operating profit148 M228 M78 M75 M
Income before tax-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M-234 M
InterestExpenseNonOperating936000.0270000.0520000.0376000.0198000.028000.08 M23 M46 M57 M
MiscOtherSpecialCharges-2 M119000.0776000.02 M2 M3 M4 M515000.04 M3 M
Net income from total operations-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M-234 M
NetIncomeCommonStockholders-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M-234 M
NetIncomeContinuousOperations-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M-234 M
NetNonOperatingInterestIncomeExpense-936000.0-270000.0-520000.0-376000.0-198000.0-28000.0-8 M-23 M-46 M-57 M
Normalized income-213 M-185 M
Operating income-23 M-36 M-50 M-76 M-169 M-205 M-93 M-121 M-227 M-180 M
Operating income before depreciation (EBITDA)-25 M-36 M-48 M-73 M-166 M-202 M-89 M-119 M-221 M-174 M
OperatingExpense-23 M-36 M-50 M-76 M-169 M-205 M241 M349 M305 M255 M
Other income net2 M-119000.0-776000.0-2 M-2 M-3 M-4 M-515000.0-4 M-3 M
OtherGandA7 M11 M20 M18 M21 M33 M66 M200 M185 M109 M
OtherOperatingExpenses-23 M-36 M-50 M-76 M-169 M-205 M241 M2 M14 M27 M
PromotionAndAdvertising19 M14 M11 M
RentAndLandingFees7 M11 M20 M18 M21 M33 M
Research & development expense16 M25 M30 M58 M148 M171 M176 M147 M106 M119 M
ResearchExpense16 M25 M30 M58 M148 M171 M176 M147 M106 M119 M
Revenue per share202000.0-29000.01 M334000.0-217000.0-200000.0-97000.012000.0279000.0
SalariesAndWages-1 M-4 M-13 M-16 M-18 M
Selling Gen & administrative expense7 M11 M20 M18 M21 M33 M66 M200 M185 M109 M
SellingAndMarketingExpense19 M14 M11 M
Total Income available for interest expense (EBIT)-25 M-36 M-49 M-75 M-167 M-202 M-89 M-121 M-223 M-177 M
Total common shares outstanding15 M20 M23 M23 M26 M27 M28 M28 M63 M77 M
Total net income-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M-234 M
Total ordinary shares114 M114 M114 M114 M114 M114 M114 M114 M114 M114 M
Total revenues148 M228 M78 M75 M
TotalExpenses-23 M-36 M-50 M-76 M-169 M-205 M241 M349 M305 M255 M
TotalRevenue148 M228 M78 M75 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University